Key points are not available for this paper at this time.
The treatment of toluene solvent and DTT additive enables the PBQ6:PYF-T- o -based all-PSC devices with PCE up to 17.06%, which is one of the highest value in non-halogenated-processed all-PSCs to date.
Hu et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: